FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,129 | -99.9% | 341,972 | -16.7% | 0.11% | -9.8% |
| Q1 2023 | $1,170,535 | -60.9% | 410,714 | 0.0% | 0.12% | -66.8% |
| Q4 2022 | $2,989,998 | -10.0% | 410,714 | 0.0% | 0.37% | -10.2% |
| Q3 2022 | $3,323,000 | +65.2% | 410,714 | 0.0% | 0.41% | +77.3% |
| Q2 2022 | $2,012,000 | -79.3% | 410,714 | 0.0% | 0.23% | -76.2% |
| Q1 2022 | $9,713,000 | +33.7% | 410,714 | 0.0% | 0.98% | +43.7% |
| Q4 2021 | $7,266,000 | -37.3% | 410,714 | 0.0% | 0.68% | +0.4% |
| Q3 2021 | $11,586,000 | +169.2% | 410,714 | 0.0% | 0.68% | +173.8% |
| Q2 2021 | $4,304,000 | -11.0% | 410,714 | 0.0% | 0.25% | -8.1% |
| Q1 2021 | $4,838,000 | +0.6% | 410,714 | 0.0% | 0.27% | +3.4% |
| Q4 2020 | $4,809,000 | +47.7% | 410,714 | 0.0% | 0.26% | +45.8% |
| Q3 2020 | $3,257,000 | -56.6% | 410,714 | 0.0% | 0.18% | -72.1% |
| Q2 2020 | $7,512,000 | +53.2% | 410,714 | 0.0% | 0.64% | -16.4% |
| Q1 2020 | $4,904,000 | -28.2% | 410,714 | 0.0% | 0.77% | +6.1% |
| Q4 2019 | $6,834,000 | +150.6% | 410,714 | 0.0% | 0.72% | +184.6% |
| Q3 2019 | $2,727,000 | – | 410,714 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $93,706,000 | 25.43% |
| TRV GP IV, LLC | 2,343,154 | $55,416,000 | 20.30% |
| COWEN AND COMPANY, LLC | 3,453,371 | $81,672,000 | 7.86% |
| Logos Global Management LP | 1,000,000 | $23,650,000 | 3.07% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $4,730,000 | 2.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,613,412 | $61,807,000 | 1.89% |
| RTW INVESTMENTS, LP | 3,611,194 | $85,405,000 | 1.77% |
| Monashee Investment Management LLC | 236,991 | $5,600,000 | 1.62% |
| Paradigm Biocapital Advisors LP | 212,961 | $5,037,000 | 1.33% |
| Parkman Healthcare Partners LLC | 164,453 | $3,889,000 | 1.14% |